A detailed history of Quadrant Capital Group LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,099 shares of VKTX stock, worth $80,095. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,099
Previous 1,106 0.63%
Holding current value
$80,095
Previous $90,000 35.56%
% of portfolio
0.0%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$47.39 - $80.2 $331 - $561
-7 Reduced 0.63%
1,099 $58,000
Q1 2024

May 15, 2024

SELL
$17.4 - $94.5 $4,976 - $27,027
-286 Reduced 20.55%
1,106 $90,000
Q2 2023

Aug 09, 2023

SELL
$14.84 - $24.79 $13,103 - $21,889
-883 Reduced 38.81%
1,392 $22,000
Q1 2023

May 11, 2023

SELL
$8.08 - $17.33 $2,375 - $5,095
-294 Reduced 11.44%
2,275 $37,000
Q4 2022

Feb 10, 2023

SELL
$2.72 - $9.4 $242 - $836
-89 Reduced 3.35%
2,569 $24,000
Q3 2022

Nov 10, 2022

SELL
$2.55 - $3.89 $991 - $1,513
-389 Reduced 12.77%
2,658 $7,000
Q2 2022

Aug 09, 2022

BUY
$2.11 - $3.15 $5,791 - $8,646
2,745 Added 908.94%
3,047 $9,000
Q1 2022

May 06, 2022

BUY
$3.0 - $4.88 $831 - $1,351
277 Added 1108.0%
302 $1,000
Q2 2021

Aug 09, 2021

BUY
$5.19 - $6.73 $129 - $168
25 New
25 $0

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.59B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.